Merck (MRK) Declares $0.48 Quarterly Dividend; 3.3% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Tech stocks power S&P 500 to record high as oil, producer inflation weaken
- Oil falls more than 3% on weaker global demand outlook and US crude buildup
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Goldman Sachs Says Merck (MRK) 'Likely to be the Dominant Player in All of NSCLC'
May 23, 2018 9:26 AM EDTMerck (NYSE: MRK) announced that its phase 3 trial in 1L squamous NSCLC, KN-407 met its dual primary endpoint of OS and PFS based on an interim analysis conducted by the DMC. Goldman Sachs expects full data at ASCO and anticipated this update after... More
Congo begins giving experimental Ebola vaccine to medics
May 21, 2018 6:51 AM EDTBy Patient Ligodi
MBANDAKA, Democratic Republic of Congo (Reuters) - Congo began administering an experimental Ebola vaccine to medical staff in the northwestern city of Mbandaka on Monday to tackle an outbreak of the virus believed to have killed 26 people since early April.
The World Health Organization (WHO) hailed the vaccinations as a "paradigm shift" in how to fight the disease which killed more than 11,300 people in a West African epidemic between 2013 and 2016.
The WHO is sending over 7,540 doses of the vaccine to the central African country, 540 of which have been earmarked for Mbandaka, a city of... More
